<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320311417655</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320311417655</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname><given-names>Furu</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
<xref ref-type="fn" rid="fn1-1470320311417655">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fang</surname><given-names>Qiaoqiao</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311417655">2</xref>
<xref ref-type="fn" rid="fn1-1470320311417655">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname><given-names>Ningle</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
<xref ref-type="fn" rid="fn1-1470320311417655">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname><given-names>Deyu</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311417655">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Yimei</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Jin</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Quan</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311417655">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhou</surname><given-names>Xianfeng</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cao</surname><given-names>Xingjiang</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fan</surname><given-names>Xiangyong</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417655">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320311417655"><label>1</label>JiangSu Provincial Center for Disease Prevention and Control, Nanjing, China</aff>
<aff id="aff2-1470320311417655"><label>2</label>Department of Respiratory Medicine, Nanjing Children’s Hospital Affiliated to Nanjing Medical University, Nanjing, China</aff>
<author-notes>
<corresp id="corresp1-1470320311417655">Furu Wang, JiangSu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing 210029, China. Email: <email>wangfuru1983@126.com</email></corresp>
<fn fn-type="other" id="fn1-1470320311417655">
<label>*</label>
<p>These authors contributed equally to this study.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<fpage>161</fpage>
<lpage>174</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Introduction</italic>: The effect of angiotensin-converting enzyme (<italic>ACE</italic>) insertion/deletion (I/D) polymorphism on risk of diabetic nephropathy (DN) is still conflicting. The present meta-analysis was performed to evaluate the overall risk of this polymorphism associated with DN in different groups.</p>
<p><italic>Materials and methods</italic>: A predefined search was performed on 14,108 DN cases and 12,472 controls from 63 published studies by searching electronic databases and reference lists of relevant articles.</p>
<p><italic>Results</italic>: In this meta-analysis, we found a significant association between the <italic>ACE</italic> I/D polymorphism and the risk of DN for all genetic models (ID versus II: odds ratio [OR] = 1.12, 95% confidence interval [CI] 1.02–1.24; DD versus II: OR = 1.27, 95% CI 1.13–1.44; allele contrast: OR = 1.15, 95% CI 1.08–1.23; dominant model: OR = 1.18, 95% CI 1.07–1.31; and recessive model: OR = 1.18, 95% CI 1.08–1.30, respectively). In stratified analysis by ethnicity and DM type, we further found that the Asian group with type 2 diabetes mellitus (T2DM) showed a significant association for all genetic models (ID versus II: OR = 1.25, 95% CI 1.07–1.47; DD versus II: OR = 1.57, 95% CI 1.24–1.98; allele contrast: OR = 1.30, 95% CI 1.15–1.46; dominant model: OR = 1.37, 95% CI 1.10–1.69; and recessive model: OR = 1.34, 95% CI 1.15–1.56, respectively).</p>
<p><italic>Conclusions</italic>: Our study suggested that the <italic>ACE</italic> I/D polymorphism may contribute to DN development, especially in the Asian group with T2DM.</p>
</abstract>
<kwd-group>
<kwd><italic>ACE</italic> I/D</kwd>
<kwd>polymorphism</kwd>
<kwd>diabetic nephropathy</kwd>
<kwd>DM type</kwd>
<kwd>genetic epidemiology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1470320311417655" sec-type="intro">
<title>Introduction</title>
<p>Diabetic nephropathy (DN) is a common and severe complication that occurs in ~40% of patients with a long-standing type II diabetes mellitus (T2DM) and in a lesser proportion of subjects with type I diabetes mellitus (T1DM),<sup><xref ref-type="bibr" rid="bibr1-1470320311417655">1</xref></sup> which is the largest single cause of end-stage renal disease (ESRD), and a medical catastrophe of worldwide dimensions.<sup><xref ref-type="bibr" rid="bibr2-1470320311417655">2</xref></sup> Abnormal microalbuminuria has emerged as a clinical risk factor for renal failure in diabetic renal disease as well as for cardiovascular disease in general and specifically in diabetes.<sup><xref ref-type="bibr" rid="bibr3-1470320311417655">3</xref></sup> However, albuminuria, elevated blood pressure and metabolic abnormalities only explain 30–50% of the variation in the progression of DN.<sup><xref ref-type="bibr" rid="bibr4-1470320311417655">4</xref>,<xref ref-type="bibr" rid="bibr5-1470320311417655">5</xref></sup> Many factors including genetic parameters are thought to contribute to this complication.<sup><xref ref-type="bibr" rid="bibr6-1470320311417655">6</xref></sup> A familial clustering of DN indicated that a genetic predisposition is implicated in the pathogenesis of DN in both types of diabetes.<sup><xref ref-type="bibr" rid="bibr7-1470320311417655">7</xref>-<xref ref-type="bibr" rid="bibr11-1470320311417655">11</xref></sup> Therefore, the etiology of DN is multifactorial and involves both environmental and genetic factors.<sup><xref ref-type="bibr" rid="bibr12-1470320311417655">12</xref></sup></p>
<p>The renin–angiotensin–aldosterone system (RAAS) has been strongly implicated in the pathogenesis of progressive renal disease.<sup><xref ref-type="bibr" rid="bibr13-1470320311417655">13</xref></sup> RAAS plays a central role in the regulation of blood pressure, sodium metabolism and renal hemodynamics, with its actions mediated primarily by angiotensin II. Angiotensin II is a powerful vasoconstrictor and intra-renal effects of the RAAS include changes in renal hemodynamics, such as an increase in intra-glomerular pressure as well as direct stimulation of mesangial cell proliferation and matrix production.<sup><xref ref-type="bibr" rid="bibr14-1470320311417655">14</xref>,<xref ref-type="bibr" rid="bibr15-1470320311417655">15</xref></sup></p>
<p>The gene encoding components of the RAAS, such as angiotensin-converting enzyme (<italic>ACE</italic>), which seem to be particularly biologically and clinically relevant to renal disease, is the most widely studied of the candidate genes of the RAAS. Inhibitors of <italic>ACE</italic> are known to be more efficient than other antihypertensives in arresting the development of DN,<sup><xref ref-type="bibr" rid="bibr16-1470320311417655">16</xref></sup> the <italic>ACE</italic> gene has a frequent insertion–deletion (I/D) polymorphism (rs4344) characterized by the presence or absence of a 278 bp Alu repetitive sequence in intron 16 and the genotypes of this polymorphism were II, ID and DD. This polymorphism was associated with circulating <italic>ACE</italic> levels and increased plasma and tissue activity of this enzyme.<sup><xref ref-type="bibr" rid="bibr17-1470320311417655">17</xref>-<xref ref-type="bibr" rid="bibr19-1470320311417655">19</xref></sup> Owing to the central role of the <italic>ACE</italic> gene in the RAAS, it is reasonable to hypothesize that genetic variation of <italic>ACE</italic> I/D contributes to the development of DN and numerous studies have addressed the role of the polymorphism in the complex etiology of DN.</p>
<p>A number of molecular epidemiological studies have been conducted to examine the association between <italic>ACE</italic> I/D polymorphism and DN,<sup><xref ref-type="bibr" rid="bibr20-1470320311417655">20</xref>-<xref ref-type="bibr" rid="bibr82-1470320311417655">82</xref></sup> but the results remain inconsistent. Although several meta-analyses have been published in 1998 and 2005, they still have not reached a consistent conclusion. To estimate the overall risk of <italic>ACE</italic> I/D polymorphism associated with diabetic nephropathy and to quantify the potential between-study heterogeneity and to provide better power to detect smaller effect sizes, we conducted a comprehensive meta-analysis on 63 published studies from 1994 to 2010 with 14,108 DN cases and 12,472 controls relating variant of the <italic>ACE</italic> I/D to the risk of developing DN.</p>
</sec>
<sec id="section2-1470320311417655">
<title>Subjects, materials and methods</title>
<sec id="section3-1470320311417655">
<title>Identification and eligibility of relevant studies</title>
<p>We attempted to include all of the studies that determined the genotype distribution of <italic>ACE</italic> I/D polymorphism in cases with diabetes and nephropathy, and (i) in diseased controls (subjects with diabetes and free of DN) or (ii) in healthy controls in our meta-analysis. Cases were type 1 or 2 diabetic subjects with incipient (microalbuminuria) or advanced DN (proteinuria/macroalbuminuria, chronic renal failure, ESRD). The diseased control group consisted of subjects with diabetes and free of diabetic kidney disease, i.e. normoalbuminuria and normal renal function.</p>
<p>We first identified studies by searching the electronic literature PubMed for relevant reports (from January 1994 to December 2010, using the search terms ‘angiotensin converting enzyme and polymorphism and nephropathy’). We chose articles which were conducted among human subjects. Eligible studies were then identified by further searching the studies published to date on the association between <italic>ACE</italic> I/D polymorphism and DN risk and restricted attention to the studies that satisfied all of the following criteria: studies related to the <italic>ACE</italic> polymorphism were included regardless of study design (case–control, cross-sectional or cohort studies); each genotype frequency was reported, and there was sufficient information for the extraction of data; if studies had partly overlapped subjects, only the one with a larger and/or latest sample size was selected for the analysis. Additional studies were identified by hands-on searches from references of original studies or review articles on this topic (<xref ref-type="fig" rid="fig1-1470320311417655">Figure 1</xref>). According to these criteria, we finally included 63 papers in our meta-analysis.</p>
<fig id="fig1-1470320311417655" position="float">
<label>Figure 1.</label>
<caption>
<p>Literature search for the meta-analysis.</p>
</caption>
<graphic xlink:href="10.1177_1470320311417655-fig1.tif"/>
</fig>
</sec>
<sec id="section4-1470320311417655">
<title>Data extraction</title>
<p>Two investigators independently extracted data and reached a consensus on all of the items. Data extracted from these articles included the first author’s name, year of publication, study design, ethnicity of the study population, type of diabetes mellitus, clinical characteristics, validity of the genotyping method and the number of cases and controls for <italic>ACE</italic> I/D genotypes. The frequencies of the alleles and the genotypic distributions were extracted or calculated for both cases and controls. In addition, it was tested whether the distribution of genotypes in the controls was consistent with Hardy–Weinberg equilibrium (HWE) for each study and calculated the frequency of the minor allele for <italic>ACE</italic> I/D polymorphism.</p>
</sec>
<sec id="section5-1470320311417655">
<title>Meta-analysis</title>
<p>Our meta-analysis examined the association between the <italic>ACE</italic> I/D polymorphism and the risk of DN for each study by odds ratio (OR) with 95% confidence intervals (CIs). For all studies, we calculated the ORs for (i) the separate pairwise comparisons, (ii) the allele contrast, (iii) the dominant model and (iv) the recessive model. In addition, we conducted stratification analysis by ethnicity and DM type. A sensitivity analysis, which examines the effect of excluding specific studies, was also performed.<sup><xref ref-type="bibr" rid="bibr83-1470320311417655">83</xref></sup> Our meta-analysis was subjected to sensitivity analysis for studies with the controls not in HWE (<italic>p</italic> &lt; 0.05).</p>
<p>The χ<sup><xref ref-type="bibr" rid="bibr2-1470320311417655">2</xref></sup>-based <italic>Q</italic> statistic test was used for the assessment of heterogeneity, and it was considered significant for <italic>p</italic> &lt; 0.05. Heterogeneity was quantified with the <italic>I<sup>2</sup></italic> metric, which is independent of the number of studies in the meta-analysis. The <italic>I</italic><sup>2</sup> metric takes values between 0 and 100%, with higher values denoting greater a degree of heterogeneity (<italic>I</italic><sup>2</sup> &gt; 50% was considered significant).<sup><xref ref-type="bibr" rid="bibr84-1470320311417655">84</xref></sup> We used the fixed-effects model and the random-effects model based on the Mantel–Haenszel method and the DerSimonian and Laird method, respectively, to combine values from each of the studies. When the effects were assumed to be homogenous, the fixed-effects model was then used; otherwise, the random-effects model was more appropriate. In addition, we further evaluated the source of heterogeneity by conducting meta-regression analyses. Publication bias was assessed according to the Egger regression asymmetry test and the Begg adjusted rank correlation test.<sup><xref ref-type="bibr" rid="bibr85-1470320311417655">85</xref>,<xref ref-type="bibr" rid="bibr86-1470320311417655">86</xref></sup> All analyses were performed by using the Statistical Analysis System software (v.9.1.3, SAS Institute, Cary, NC) and Stata soft (v.11.0). All of the <italic>p</italic>-values were two-sided.</p>
</sec>
</sec>
<sec id="section6-1470320311417655" sec-type="results">
<title>Results</title>
<sec id="section7-1470320311417655">
<title>Eligible studies and study characteristics</title>
<p>The selected study characteristics from the studies included in the meta-analysis are provided in <xref ref-type="table" rid="table1-1470320311417655">Table 1</xref>. In all studies, valid genotyping methods were used: polymerase chain reaction (PCR) and restriction of the PCR product with the corresponding enzyme or PCR with allele-specific probes, and electrophoretic differentiation. A total of 22 studies (19 White, 3 Asian) involved cases with T1DM and 42 (15 White, 27 Asian) with T2DM. The studies on T1DM Whites contributed 3,036 cases and 3,475 control subjects, while the Asian studies included 181 cases and 141 control subjects. Among the T2DM studies, studies involving Whites contributed 5,370 cases and 3,727 control subjects, while the Asian studies included 5,521 cases and 5,129 control subjects. A total of 32 studies used a case–control study design, 24 studies used a cross-sectional study design, and 7 studies used a cohort study design.</p>
<table-wrap id="table1-1470320311417655" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of published studies included in the meta-analysis.</p>
</caption>
<graphic alternate-form-of="table1-1470320311417655" xlink:href="10.1177_1470320311417655-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Author (reference)</th>
<th align="left">Year</th>
<th align="left">Ethnicity</th>
<th align="left">Design</th>
<th align="left">Type of DM</th>
<th align="left" colspan="4">Case</th>
<th align="left" colspan="6">Control</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th/>
<th align="left">Sample size</th>
<th align="left">Age (years)</th>
<th align="left">DM duration (years)</th>
<th align="left">Definition (renal status)</th>
<th align="left">Sample size</th>
<th align="left">Age (years)</th>
<th align="left">DM duration (years)</th>
<th align="left">Status</th>
<th align="left">HWE</th>
<th align="left">MAF</th>
</tr>
</thead>
<tbody>
<tr>
<td>Doria<sup><xref ref-type="bibr" rid="bibr20-1470320311417655">20</xref></sup></td>
<td>1994</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>74</td>
<td>NR</td>
<td>NR</td>
<td>Micro, Prot, ESRD</td>
<td>77</td>
<td>NR</td>
<td>NR</td>
<td>Normo</td>
<td>0.55</td>
<td>0.47</td>
</tr>
<tr>
<td>Powrie<sup><xref ref-type="bibr" rid="bibr21-1470320311417655">21</xref></sup></td>
<td>1994</td>
<td>White</td>
<td>CH</td>
<td>1</td>
<td>19</td>
<td>NR</td>
<td>15.1±8.5</td>
<td>Micro</td>
<td>85</td>
<td>NR</td>
<td>16.1±9.0</td>
<td>Normo after 10 years follow-up</td>
<td>0.23</td>
<td>0.50</td>
</tr>
<tr>
<td>Dudley<sup><xref ref-type="bibr" rid="bibr22-1470320311417655">22</xref></sup></td>
<td>1995</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>163</td>
<td>53.0±8.0</td>
<td>NR</td>
<td>Top tertile of albuminuria</td>
<td>267</td>
<td>53.0±8.0</td>
<td>NR</td>
<td>Excluding top tertile</td>
<td>0.06</td>
<td>0.54</td>
</tr>
<tr>
<td>Fujisawa<sup><xref ref-type="bibr" rid="bibr23-1470320311417655">23</xref></sup></td>
<td>1995</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>54</td>
<td>NA</td>
<td>NA</td>
<td>Prot, HD</td>
<td>35</td>
<td>NA</td>
<td>NA</td>
<td>No Prot with DM≥10 years</td>
<td>0.16</td>
<td>0.34</td>
</tr>
<tr>
<td>Mizuiri<sup><xref ref-type="bibr" rid="bibr24-1470320311417655">24</xref></sup></td>
<td>1995</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>80</td>
<td>NR</td>
<td>NR</td>
<td>Micro, Prot, CRF</td>
<td>31</td>
<td>NR</td>
<td>NR</td>
<td>Normo, with DM≥10 years</td>
<td>0.11</td>
<td>0.47</td>
</tr>
<tr>
<td>Panagiotopoulos<sup><xref ref-type="bibr" rid="bibr25-1470320311417655">25</xref></sup></td>
<td>1995</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>50</td>
<td>61.9±1.8</td>
<td>15.2±2.0</td>
<td>Micro, Prot, CRF</td>
<td>115</td>
<td>64.4±0.9</td>
<td>13.3±1.5</td>
<td>Normo</td>
<td>0.02</td>
<td>0.56</td>
</tr>
<tr>
<td>Schmidt<sup><xref ref-type="bibr" rid="bibr26-1470320311417655">26</xref></sup></td>
<td>1995</td>
<td>White</td>
<td>CH</td>
<td>1</td>
<td>114</td>
<td>45.0±15.5</td>
<td>22.7±9.1</td>
<td>Micro at least</td>
<td>133</td>
<td>44.0±15.4</td>
<td>25.1±3.5</td>
<td>Normo</td>
<td>0.16</td>
<td>0.62</td>
</tr>
<tr>
<td>Tarnow<sup><xref ref-type="bibr" rid="bibr27-1470320311417655">27</xref></sup></td>
<td>1995</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>198</td>
<td>40.9±10.0</td>
<td>27.0±8.0</td>
<td>Prot</td>
<td>190</td>
<td>42.7±10.0</td>
<td>26.0±8.0</td>
<td>Normo</td>
<td>0.01</td>
<td>0.56</td>
</tr>
<tr>
<td>Chowdhury<sup><xref ref-type="bibr" rid="bibr28-1470320311417655">28</xref></sup></td>
<td>1996</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>242</td>
<td>NR</td>
<td>27.6±8.0</td>
<td>Prot</td>
<td>166</td>
<td>NR</td>
<td>26.7±8.7</td>
<td>No Prot with DM≥15 years</td>
<td>0.70</td>
<td>0.57</td>
</tr>
<tr>
<td>Doi<sup><xref ref-type="bibr" rid="bibr29-1470320311417655">29</xref></sup></td>
<td>1996</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>164</td>
<td>Micro:62.0±12.0 Prot/CRF:63.0±11.0 HD:62.0±11.0</td>
<td>Micro:18.0±5.0 Prot/CRF:21.0±7.0 HD:21.0±8.0</td>
<td>Micro, Prot, CRF, HD</td>
<td>124</td>
<td>61.0±10.0</td>
<td>5.0±3.0</td>
<td>Normo with DM&lt;10 years</td>
<td>0.71</td>
<td>0.32</td>
</tr>
<tr>
<td>Nakajima<sup><xref ref-type="bibr" rid="bibr30-1470320311417655">30</xref></sup></td>
<td>1996</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>101</td>
<td>Micro:57.0±7.9 Prot:56.0±6.7</td>
<td>Micro:12.7±5.9 Prot:14.9±5.2</td>
<td>Micro, Prot</td>
<td>41</td>
<td>55.0±6.0</td>
<td>14.1±5.4</td>
<td>Normo</td>
<td>0.75</td>
<td>0.33</td>
</tr>
<tr>
<td>Oh<sup><xref ref-type="bibr" rid="bibr31-1470320311417655">31</xref></sup></td>
<td>1996</td>
<td>Asian</td>
<td>CS</td>
<td>1</td>
<td>31</td>
<td>34.6±12.6</td>
<td>10.9±5.2</td>
<td>Micro, Prot, ESRD</td>
<td>28</td>
<td>35.7±9.8</td>
<td>9.7±4.2</td>
<td>Normo</td>
<td>0.15</td>
<td>0.43</td>
</tr>
<tr>
<td>Ohno<sup><xref ref-type="bibr" rid="bibr32-1470320311417655">32</xref></sup></td>
<td>1996</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>79</td>
<td>Micro:60.5±7.2 Macro:62.4±9.8</td>
<td>Micro:13.8±6.7 Macro:13.1±5.9</td>
<td>Micro, Macro</td>
<td>53</td>
<td>60.3±8.6</td>
<td>12.8±7.6</td>
<td>Normo</td>
<td>0.12</td>
<td>0.24</td>
</tr>
<tr>
<td>Yoshida<sup><xref ref-type="bibr" rid="bibr33-1470320311417655">33</xref></sup></td>
<td>1996</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>72</td>
<td>61.1±1.1</td>
<td>18.7±0.8</td>
<td>CRF, ESRD</td>
<td>96</td>
<td>63.8±1.0</td>
<td>20.4±0.6</td>
<td>Stable renal function</td>
<td>0.26</td>
<td>0.31</td>
</tr>
<tr>
<td>Barnas<sup><xref ref-type="bibr" rid="bibr34-1470320311417655">34</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>50</td>
<td>46.0±11.0</td>
<td>27.6±10.0</td>
<td>Micro, Prot, CRF, HD</td>
<td>40</td>
<td>43.0±12.0</td>
<td>24.0±10.0</td>
<td>Normo with DM&gt;20 years</td>
<td>0.39</td>
<td>0.36</td>
</tr>
<tr>
<td>Hibberd<sup><xref ref-type="bibr" rid="bibr35-1470320311417655">35</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>72</td>
<td>43.0±11.6</td>
<td>26.9±8.4</td>
<td>Prot</td>
<td>86</td>
<td>50.9±13.6</td>
<td>31.5±9.4</td>
<td>Normo with DM≥20 years</td>
<td>0.23</td>
<td>0.67</td>
</tr>
<tr>
<td>Jeffers<sup><xref ref-type="bibr" rid="bibr36-1470320311417655">36</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CS</td>
<td>2</td>
<td>50</td>
<td>NR</td>
<td>NR</td>
<td>Prot</td>
<td>459</td>
<td>NR</td>
<td>NR</td>
<td>No Prot</td>
<td>0.35</td>
<td>0.54</td>
</tr>
<tr>
<td>Marre<sup><xref ref-type="bibr" rid="bibr37-1470320311417655">37</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CS</td>
<td>1</td>
<td>337</td>
<td>Incipient:43.0±13.0 Established:43.0±12.0 Advanced:44.0±11.0</td>
<td>Incipient:27.0±9.0 Established:27.0±9.0 Advanced:28.0±9.0</td>
<td>Micro, Prot, CRF, ESRD</td>
<td>157</td>
<td>46.0±13.0</td>
<td>16.0±9.0</td>
<td>Normo</td>
<td>0.14</td>
<td>0.53</td>
</tr>
<tr>
<td>Ringel<sup><xref ref-type="bibr" rid="bibr38-1470320311417655">38</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CS</td>
<td>1</td>
<td>134</td>
<td>38.9±13.1</td>
<td>18.8±10.5</td>
<td>Micro, ESRD</td>
<td>226</td>
<td>35.7±11.4</td>
<td>14.8±10.3</td>
<td>Normo</td>
<td>0.02</td>
<td>0.54</td>
</tr>
<tr>
<td>Ringel<sup><xref ref-type="bibr" rid="bibr38-1470320311417655">38</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CS</td>
<td>2</td>
<td>161</td>
<td>61.4±10.6</td>
<td>14.4±9.4</td>
<td>Micro, ESRD</td>
<td>140</td>
<td>58.6±9.6</td>
<td>11.6±7.9</td>
<td>Normo</td>
<td>0.87</td>
<td>0.49</td>
</tr>
<tr>
<td>Demurov<sup><xref ref-type="bibr" rid="bibr39-1470320311417655">39</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>56</td>
<td>NA</td>
<td>NA</td>
<td>Prot</td>
<td>76</td>
<td>NA</td>
<td>NA</td>
<td>Normo</td>
<td>0.18</td>
<td>0.53</td>
</tr>
<tr>
<td>Schmidt<sup><xref ref-type="bibr" rid="bibr40-1470320311417655">40</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>311</td>
<td>65.0±9.0</td>
<td>19.0±7.0</td>
<td>Micro at least, ESRD</td>
<td>347</td>
<td>63.0±9.0</td>
<td>17.0±6.0</td>
<td>Normo with DM≥10 years</td>
<td>0.16</td>
<td>0.60</td>
</tr>
<tr>
<td>Gutierrez<sup><xref ref-type="bibr" rid="bibr41-1470320311417655">41</xref></sup></td>
<td>1997</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>193</td>
<td>Micro:60.1±10.6 Prot:64.2±9.2</td>
<td>Micro:15.1±6.2 Prot:16.1±7.1</td>
<td>Micro, Prot</td>
<td>90</td>
<td>59.7±9.9</td>
<td>12.0±5.5</td>
<td>Normo</td>
<td>0.03</td>
<td>0.57</td>
</tr>
<tr>
<td>Pfohl<sup><xref ref-type="bibr" rid="bibr42-1470320311417655">42</xref></sup></td>
<td>1998</td>
<td>White</td>
<td>CS</td>
<td>1</td>
<td>40</td>
<td>40.7±10.6</td>
<td>22.8±9.7</td>
<td>Micro, Prot, HD</td>
<td>40</td>
<td>40.2±12.1</td>
<td>22.4±7.2</td>
<td>Normo</td>
<td>0.69</td>
<td>0.60</td>
</tr>
<tr>
<td>Freire<sup><xref ref-type="bibr" rid="bibr43-1470320311417655">43</xref></sup></td>
<td>1998</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>77</td>
<td>NR</td>
<td>18.0±6.0</td>
<td>Micro at least</td>
<td>89</td>
<td>NR</td>
<td>17.0±6.0</td>
<td>Normo</td>
<td>0.39</td>
<td>0.63</td>
</tr>
<tr>
<td>Grzeszczak<sup><xref ref-type="bibr" rid="bibr44-1470320311417655">44</xref></sup></td>
<td>1998</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>462</td>
<td>Micro:61.8±9.4 Prot:62.5±9.3</td>
<td>Micro:13.8±6.7 Prot:14.7±6.6</td>
<td>Micro, Prot, CRF</td>
<td>254</td>
<td>62.7±8.3</td>
<td>16.7±5.2</td>
<td>Normo with DM&gt;10 years</td>
<td>0.27</td>
<td>0.52</td>
</tr>
<tr>
<td>Hanyu<sup><xref ref-type="bibr" rid="bibr45-1470320311417655">45</xref></sup></td>
<td>1998</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>24</td>
<td>56.1±10.5</td>
<td>17.0±6.0</td>
<td>Micro at least</td>
<td>21</td>
<td>60.0±8.8</td>
<td>18.2±5.7</td>
<td>Normo</td>
<td>0.18</td>
<td>0.21</td>
</tr>
<tr>
<td>Huang<sup><xref ref-type="bibr" rid="bibr46-1470320311417655">46</xref></sup></td>
<td>1998</td>
<td>White</td>
<td>CH</td>
<td>2</td>
<td>19</td>
<td>NR</td>
<td>NR</td>
<td>Micro, Prot</td>
<td>54</td>
<td>NR</td>
<td>NR</td>
<td>Normo after 9 years follow-up</td>
<td>0.80</td>
<td>0.60</td>
</tr>
<tr>
<td>Wu<sup><xref ref-type="bibr" rid="bibr47-1470320311417655">47</xref></sup></td>
<td>1998</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>51</td>
<td>NR</td>
<td>NR</td>
<td>Diabetic nephropathy not explicitly</td>
<td>18</td>
<td>NR</td>
<td>NR</td>
<td>No diabetic nephropathy</td>
<td>0.17</td>
<td>0.36</td>
</tr>
<tr>
<td>Bouhanick<sup><xref ref-type="bibr" rid="bibr48-1470320311417655">48</xref></sup></td>
<td>1999</td>
<td>White</td>
<td>CS</td>
<td>1</td>
<td>13</td>
<td>NR</td>
<td>NR</td>
<td>Micro</td>
<td>63</td>
<td>NR</td>
<td>NR</td>
<td>Normo</td>
<td>0.42</td>
<td>0.57</td>
</tr>
<tr>
<td>De Cosmo<sup><xref ref-type="bibr" rid="bibr49-1470320311417655">49</xref></sup></td>
<td>1999</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>175</td>
<td>43.0±11.0</td>
<td>25.0±9.0</td>
<td>Micro at least</td>
<td>136</td>
<td>43.0±13.0</td>
<td>25.0±8.0</td>
<td>Normo with DM&gt;15 years</td>
<td>0.18</td>
<td>0.67</td>
</tr>
<tr>
<td>Kuramoto<sup><xref ref-type="bibr" rid="bibr50-1470320311417655">50</xref></sup></td>
<td>1999</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>33</td>
<td>Micro:58.9±2.6 Macro/Prot:56.9±3.4</td>
<td>Micro:11.4±2.3 Macro/Prot:9.5±2.1</td>
<td>Micro, Prot</td>
<td>29</td>
<td>59.4±1.9</td>
<td>10.8±1.0</td>
<td>Normo with DM&gt;5 years</td>
<td>0.92</td>
<td>0.33</td>
</tr>
<tr>
<td>Miura<sup><xref ref-type="bibr" rid="bibr51-1470320311417655">51</xref></sup></td>
<td>1999</td>
<td>Asian</td>
<td>CS</td>
<td>1</td>
<td>98</td>
<td>Incipient:34.8±7.3 Clinical:37.6±7.0</td>
<td>Incipient:11.4±6.7 Clinical :12.6±7.5</td>
<td>Micro, Macro, CRF, ESRD</td>
<td>103</td>
<td>33.5±8.6</td>
<td>13.4±7.3</td>
<td>Normo with DM&gt;10 years</td>
<td>0.05</td>
<td>0.38</td>
</tr>
<tr>
<td>Vleming<sup><xref ref-type="bibr" rid="bibr52-1470320311417655">52</xref></sup></td>
<td>1999</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>79</td>
<td>NA</td>
<td>NA</td>
<td>ESRD</td>
<td>82</td>
<td>NA</td>
<td>NA</td>
<td>Normo with DM&gt;15 years</td>
<td>0.13</td>
<td>0.52</td>
</tr>
<tr>
<td>Wong<sup><xref ref-type="bibr" rid="bibr53-1470320311417655">53</xref></sup></td>
<td>1999</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>80</td>
<td>62.0±10.0</td>
<td>13.8±5.3</td>
<td>Prot, CRF, ESRD</td>
<td>88</td>
<td>62.0±11.0</td>
<td>13.5±5.0</td>
<td>Normo, micro with DM&gt;10 years</td>
<td>0.87</td>
<td>0.36</td>
</tr>
<tr>
<td>Tomino<sup><xref ref-type="bibr" rid="bibr54-1470320311417655">54</xref></sup></td>
<td>1999</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>757</td>
<td>Micro:60.6±12.5 Overt:60.9±10.5</td>
<td>Micro:14.5±8.8 Overt:18.2±8.3</td>
<td>Micro at least</td>
<td>380</td>
<td>61.7±11.4</td>
<td>17.8±6.6</td>
<td>Normo with DM&gt;10 years</td>
<td>0.92</td>
<td>0.37</td>
</tr>
<tr>
<td>Hsieh<sup><xref ref-type="bibr" rid="bibr55-1470320311417655">55</xref>e&gt;</sup></td>
<td>2000</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>179</td>
<td>Prot:59.6±9.5 HD:61.6±9.6</td>
<td>Prot:12.1±4.9 HD:11.2±4.4</td>
<td>Prot, HD</td>
<td>157</td>
<td>59.5±10.4</td>
<td>10.7±4.4</td>
<td>No Prot</td>
<td>0.00</td>
<td>0.29</td>
</tr>
<tr>
<td>van Ittersum<sup><xref ref-type="bibr" rid="bibr56-1470320311417655">56</xref></sup></td>
<td>2000</td>
<td>White</td>
<td>CS</td>
<td>1</td>
<td>200</td>
<td>Micro:50.6±15.3 Macro:57.7±11.8</td>
<td>Micro:20.6±9.8 Macro:20.8±11.2</td>
<td>Micro at least</td>
<td>100</td>
<td>42.2±13.7</td>
<td>15.5±11.3</td>
<td>Normo</td>
<td>0.43</td>
<td>0.49</td>
</tr>
<tr>
<td>Araz<sup><xref ref-type="bibr" rid="bibr57-1470320311417655">57</xref></sup></td>
<td>2001</td>
<td>White</td>
<td>CS</td>
<td>2</td>
<td>116</td>
<td>Micro:54.0±8.0 Macro:57.0±7.0</td>
<td>Micro:8.8±5.8 Macro:12.3±6.9</td>
<td>Micro, Macro</td>
<td>123</td>
<td>51.0±9.0</td>
<td>6.4±5.8</td>
<td>Normo</td>
<td>0.59</td>
<td>0.58</td>
</tr>
<tr>
<td>Azar<sup><xref ref-type="bibr" rid="bibr58-1470320311417655">58</xref></sup></td>
<td>2001</td>
<td>Asian</td>
<td>CC</td>
<td>1</td>
<td>52</td>
<td>22.8±5.2</td>
<td>13.8±5.8</td>
<td>Micro, Prot, ESRD</td>
<td>10</td>
<td>26.0±9.0</td>
<td>20.7±7.4</td>
<td>Normo with DM&gt;15 years</td>
<td>0.19</td>
<td>0.45</td>
</tr>
<tr>
<td>Gohda<sup><xref ref-type="bibr" rid="bibr59-1470320311417655">59</xref></sup></td>
<td>2001</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>536</td>
<td>NA</td>
<td>NA</td>
<td>Micro, Prot, CRF, ESRD</td>
<td>212</td>
<td>NA</td>
<td>NA</td>
<td>Normo with DM&gt;15 years</td>
<td>0.37</td>
<td>0.36</td>
</tr>
<tr>
<td>Taniwaki<sup><xref ref-type="bibr" rid="bibr60-1470320311417655">60</xref></sup></td>
<td>2001</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>86</td>
<td>Micro:60.5±8.5 Pro:59.0±10.5 CRF:64.2±7.8</td>
<td>Micro:10.9±7.4 Pro:12.8±6.5 CRF:19.1±9.7</td>
<td>Micro, Prot, CRF</td>
<td>69</td>
<td>60.1±9.8</td>
<td>7.4±4.5</td>
<td>Normo</td>
<td>0.13</td>
<td>0.36</td>
</tr>
<tr>
<td>Viswanathan<sup><xref ref-type="bibr" rid="bibr61-1470320311417655">61</xref></sup></td>
<td>2001</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>86</td>
<td>56.7±8.9</td>
<td>13.4±6.9</td>
<td>Prot</td>
<td>23</td>
<td>56.7±9.3</td>
<td>13.2±5.1</td>
<td>Normo</td>
<td>0.20</td>
<td>0.39</td>
</tr>
<tr>
<td>Fradin<sup><xref ref-type="bibr" rid="bibr62-1470320311417655">62</xref></sup></td>
<td>2002</td>
<td>White</td>
<td>CS</td>
<td>2</td>
<td>117</td>
<td>Incipient:56.8±9.4 Estabilshed:57.9±9.3</td>
<td>Incipient:9.8±8.4 Estabilshed:15.4±9.3</td>
<td>Micro at least</td>
<td>118</td>
<td>55.2±8.3</td>
<td>9.5±8.1</td>
<td>Normo</td>
<td>0.62</td>
<td>0.40</td>
</tr>
<tr>
<td>Lee<sup><xref ref-type="bibr" rid="bibr63-1470320311417655">63</xref></sup></td>
<td>2002</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>294</td>
<td>NR</td>
<td>NR</td>
<td>Micro at least</td>
<td>417</td>
<td>NR</td>
<td>NR</td>
<td>Normo</td>
<td>0.62</td>
<td>0.30</td>
</tr>
<tr>
<td>Ha<sup><xref ref-type="bibr" rid="bibr64-1470320311417655">64</xref></sup></td>
<td>2003</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>140</td>
<td>60.7±10.1</td>
<td>17.2±5.5</td>
<td>CRF, ESRD</td>
<td>99</td>
<td>59.9±10.6</td>
<td>19.7±3.5</td>
<td>Normo with DM&gt;15 years</td>
<td>0.03</td>
<td>0.38</td>
</tr>
<tr>
<td>Hadjadj<sup><xref ref-type="bibr" rid="bibr65-1470320311417655">65</xref></sup></td>
<td>2003</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>3139</td>
<td>65.7±8.3</td>
<td>10.3±7.7</td>
<td>Micro at least</td>
<td>605</td>
<td>65.0±7.3</td>
<td>8.3±6.9</td>
<td>Normo</td>
<td>0.27</td>
<td>0.57</td>
</tr>
<tr>
<td>Okuno<sup><xref ref-type="bibr" rid="bibr66-1470320311417655">66</xref></sup></td>
<td>2003</td>
<td>Asian</td>
<td>CH</td>
<td>2</td>
<td>12</td>
<td>68.6±8.1</td>
<td>11.4±6.1</td>
<td>Micro</td>
<td>38</td>
<td>67.6±10.0</td>
<td>9.7±7.9</td>
<td>Normo</td>
<td>0.15</td>
<td>0.29</td>
</tr>
<tr>
<td>Chang<sup><xref ref-type="bibr" rid="bibr67-1470320311417655">67</xref></sup></td>
<td>2003</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>129</td>
<td>61.8±11.1</td>
<td>14.9±8.6</td>
<td>ESRD</td>
<td>116</td>
<td>60.4±12.4</td>
<td>NR</td>
<td>Healthy</td>
<td>0.13</td>
<td>0.30</td>
</tr>
<tr>
<td>Arzu Ergen<sup><xref ref-type="bibr" rid="bibr68-1470320311417655">68</xref></sup></td>
<td>2004</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>25</td>
<td>59.6±13.5</td>
<td>14.6±10.4</td>
<td>Macro, CRF</td>
<td>50</td>
<td>57.1±14.5</td>
<td>13.0±9.2</td>
<td>Normo</td>
<td>0.90</td>
<td>0.69</td>
</tr>
<tr>
<td>Park<sup><xref ref-type="bibr" rid="bibr69-1470320311417655">69</xref></sup></td>
<td>2005</td>
<td>Asian</td>
<td>CS</td>
<td>2</td>
<td>103</td>
<td>60.3±10.1</td>
<td>17.5±5.7</td>
<td>ESRD</td>
<td>88</td>
<td>60.1±11.0</td>
<td>19.6±3.4</td>
<td>Normo with DM&gt;15 years</td>
<td>0.02</td>
<td>0.37</td>
</tr>
<tr>
<td>Canani<sup><xref ref-type="bibr" rid="bibr70-1470320311417655">70</xref></sup></td>
<td>2005</td>
<td>White</td>
<td>CS</td>
<td>2</td>
<td>373</td>
<td>NR</td>
<td>NR</td>
<td>Micro, Macro, CRF</td>
<td>609</td>
<td>NR</td>
<td>NR</td>
<td>Normo</td>
<td>0.59</td>
<td>0.55</td>
</tr>
<tr>
<td>Prasad<sup><xref ref-type="bibr" rid="bibr71-1470320311417655">71</xref></sup></td>
<td>2006</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>196</td>
<td>57±12.8</td>
<td>10.4±7.7</td>
<td>Micro, CRF</td>
<td>225</td>
<td>60.6±11.5</td>
<td>17.1±6.7</td>
<td>Normo</td>
<td>0.06</td>
<td>0.45</td>
</tr>
<tr>
<td>Buraczynska<sup><xref ref-type="bibr" rid="bibr72-1470320311417655">72</xref></sup></td>
<td>2006</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>141</td>
<td>51.1±11.6</td>
<td>NR</td>
<td>ESRD</td>
<td>520</td>
<td>48.3±9.6</td>
<td>NR</td>
<td>Healthy</td>
<td>0.44</td>
<td>0.47</td>
</tr>
<tr>
<td>So<sup><xref ref-type="bibr" rid="bibr73-1470320311417655">73</xref></sup></td>
<td>2006</td>
<td>Asian</td>
<td>CH</td>
<td>2</td>
<td>864</td>
<td>NR</td>
<td>NR</td>
<td>Micro, Macro</td>
<td>1225</td>
<td>NR</td>
<td>NR</td>
<td>Normo</td>
<td>0.17</td>
<td>0.34</td>
</tr>
<tr>
<td>Osawa<sup><xref ref-type="bibr" rid="bibr74-1470320311417655">74</xref></sup></td>
<td>2007</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>723</td>
<td>60.1±11.7</td>
<td>19.3±9.7</td>
<td>Micro, CRF</td>
<td>521</td>
<td>62.4±10.4</td>
<td>15.3±8.9</td>
<td>Normo</td>
<td>0.17</td>
<td>0.33</td>
</tr>
<tr>
<td>Hadjadj<sup><xref ref-type="bibr" rid="bibr75-1470320311417655">75</xref></sup></td>
<td>2007</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>1042</td>
<td>42.0±10.2</td>
<td>28.4±8.7</td>
<td>Macro, CRF</td>
<td>1123</td>
<td>44.8±11.0</td>
<td>29.2±9.0</td>
<td>Normo</td>
<td>0.00</td>
<td>0.53</td>
</tr>
<tr>
<td>Movva<sup><xref ref-type="bibr" rid="bibr76-1470320311417655">76</xref></sup></td>
<td>2007</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>174</td>
<td>57.2±10.5</td>
<td>15.5±5.2</td>
<td>Micro, CRF, ESRD</td>
<td>175</td>
<td>55.5±10.8</td>
<td>14.1±5.1</td>
<td>Normo with DM&gt;10 years</td>
<td>0.24</td>
<td>0.37</td>
</tr>
<tr>
<td>Mollsten<sup><xref ref-type="bibr" rid="bibr77-1470320311417655">77</xref></sup></td>
<td>2008</td>
<td>White</td>
<td>CC</td>
<td>1</td>
<td>73</td>
<td>Incipient:47.0±10.7 Overt :48.1±10.3</td>
<td>Incipient:34 Overt:30</td>
<td>Micro at least</td>
<td>197</td>
<td>43.9±11.3</td>
<td>30</td>
<td>Normo</td>
<td>0.03</td>
<td>0.47</td>
</tr>
<tr>
<td>Gallego<sup><xref ref-type="bibr" rid="bibr78-1470320311417655">78</xref></sup></td>
<td>2008</td>
<td>White</td>
<td>CH</td>
<td>1</td>
<td>41</td>
<td>15.6</td>
<td>8.2</td>
<td>Micro</td>
<td>409</td>
<td>16.8</td>
<td>6.7</td>
<td>Normo</td>
<td>0.96</td>
<td>0.49</td>
</tr>
<tr>
<td>Eroglu<sup><xref ref-type="bibr" rid="bibr79-1470320311417655">79</xref></sup></td>
<td>2008</td>
<td>White</td>
<td>CC</td>
<td>2</td>
<td>46</td>
<td>58.3±10.5</td>
<td>8.8±7.1</td>
<td>Micro</td>
<td>56</td>
<td>52.3±9.5</td>
<td>7.1±5.2</td>
<td>Normo</td>
<td>0.32</td>
<td>0.47</td>
</tr>
<tr>
<td>Tien<sup><xref ref-type="bibr" rid="bibr80-1470320311417655">80</xref></sup></td>
<td>2009</td>
<td>Asian</td>
<td>CH</td>
<td>2</td>
<td>93</td>
<td>female:61.0±14.4 male:57.7±10.3</td>
<td>NR</td>
<td>Micro at least</td>
<td>432</td>
<td>female: 59.5±11.0 male: 58.4±11.2</td>
<td>NR</td>
<td>Normo</td>
<td>0.73</td>
<td>0.34</td>
</tr>
<tr>
<td>Ahluwalia<sup><xref ref-type="bibr" rid="bibr81-1470320311417655">81</xref></sup></td>
<td>2009</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>240</td>
<td>58.4±5.8</td>
<td>15.7±4.1</td>
<td>Macro, CRF, ESRD</td>
<td>255</td>
<td>54.9±7.6</td>
<td>15.3±1.7</td>
<td>Normo</td>
<td>0.34</td>
<td>0.42</td>
</tr>
<tr>
<td>Jayapalan<sup><xref ref-type="bibr" rid="bibr82-1470320311417655">82</xref></sup></td>
<td>2010</td>
<td>Asian</td>
<td>CC</td>
<td>2</td>
<td>175</td>
<td>Micro:59.8±10.2 Prot:62.7±9.5 ESRD:57.2±9.0</td>
<td>Micro:13.1±9.4 Prot:16.3±9.4 ESRD:18.6±6.9</td>
<td>Micro, Prot, ESRD</td>
<td>81</td>
<td>57.0±10.2</td>
<td>10.2±7.9</td>
<td>Normo</td>
<td>0.05</td>
<td>0.43</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320311417655">
<p><sup>#</sup> Hardy–Weinberg equilibrium (HWE) test and *the minor allele frequency (MAF) were calculated in control group for each study. NR, not reported; NA, not available; DM, diabetes mellitus; CC, case–control; CS, cross-sectional; CH, cohort; Normo, nonrmoalbuminuria; Micro, microalbuminuria; Prot, proteinuria; Macro, macroalbuminuria; CRF, chronic renal failure; ESRD, end-stage renal disease; HD, hemodialysis; DM, diabetes mellitus.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-1470320311417655">
<title>Summary statistics</title>
<p>Data from 63 articles that investigated the association between the <italic>ACE</italic> I/D polymorphism and DN were included in the meta-analysis. The overall frequency (%) of minor A allele frequency (MAF) was 0.50/0.47 for cases and controls. The frequency of the MAF for each individual study polymorphism for controls is given in <xref ref-type="table" rid="table1-1470320311417655">Table 1</xref>.</p>
<p>All studies indicated that the distribution of genotypes in the controls was consistent with Hardy–Weinberg equilibrium except for nine studies,<sup><xref ref-type="bibr" rid="bibr25-1470320311417655">25</xref>,<xref ref-type="bibr" rid="bibr27-1470320311417655">27</xref>,<xref ref-type="bibr" rid="bibr38-1470320311417655">38</xref>,<xref ref-type="bibr" rid="bibr41-1470320311417655">41</xref>,<xref ref-type="bibr" rid="bibr55-1470320311417655">55</xref>,<xref ref-type="bibr" rid="bibr64-1470320311417655">64</xref>,<xref ref-type="bibr" rid="bibr69-1470320311417655">69</xref>,<xref ref-type="bibr" rid="bibr75-1470320311417655">75</xref>,<xref ref-type="bibr" rid="bibr77-1470320311417655">77</xref></sup> indicating genotyping errors and/or population stratification;<sup><xref ref-type="bibr" rid="bibr83-1470320311417655">83</xref></sup> therefore, a sensitivity analysis was performed excluding these studies.</p>
</sec>
<sec id="section9-1470320311417655">
<title>Main results, stratification, and sensitivity analyses</title>
<p>The evaluations of the association of <italic>ACE</italic> I/D polymorphism with DN are presented in <xref ref-type="table" rid="table2-1470320311417655">Table 2</xref>. <xref ref-type="fig" rid="fig2-1470320311417655">Figure 2</xref> shows the overall and subgroup results for the association between the polymorphism and the risk of DN (in the dominant model).</p>
<table-wrap id="table2-1470320311417655" position="float">
<label>Table 2.</label>
<caption>
<p>Summary odds ratios (ORs) and heterogeneity results for associations between the <italic>ACE</italic> I/D polymorphism and diabetic nephropathy.</p>
</caption>
<graphic alternate-form-of="table2-1470320311417655" xlink:href="10.1177_1470320311417655-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Genetic model</th>
<th align="left">Population</th>
<th align="left">Studies</th>
<th align="left">OR</th>
<th align="left">95%CI</th>
<th align="left"><italic>p</italic><xref ref-type="table-fn" rid="table-fn2-1470320311417655">*</xref></th>
<th align="left"><italic>I</italic><sup>2</sup> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>ID versus II</td>
<td>All studies</td>
<td>63</td>
<td>1.12</td>
<td>1.02–1.24</td>
<td>0.00</td>
<td>43.7</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic White</td>
<td>19</td>
<td>1.07</td>
<td>0.94–1.23</td>
<td>0.11</td>
<td>29.7</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic Asian</td>
<td>3</td>
<td>0.90</td>
<td>0.53–1.51</td>
<td>0.39</td>
<td>0.0</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic White</td>
<td>15</td>
<td>1.01</td>
<td>0.89–1.15</td>
<td>0.19</td>
<td>24.4</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic Asian</td>
<td>27</td>
<td>1.25</td>
<td>1.07–1.47</td>
<td>0.00</td>
<td>58.3</td>
</tr>
<tr>
<td>DD versus II</td>
<td>All studies</td>
<td>63</td>
<td>1.27</td>
<td>1.13–1.44</td>
<td>0.00</td>
<td>47.8</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic White</td>
<td>19</td>
<td>1.17</td>
<td>0.93–1.46</td>
<td>0.03</td>
<td>42.2</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic Asian</td>
<td>3</td>
<td>1.54</td>
<td>0.75–3.16</td>
<td>0.15</td>
<td>47.5</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic White</td>
<td>15</td>
<td>1.10</td>
<td>0.96–1.26</td>
<td>0.83</td>
<td>0.0</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic Asian</td>
<td>27</td>
<td>1.57</td>
<td>1.24–1.98</td>
<td>0.00</td>
<td>63.5</td>
</tr>
<tr>
<td>Allele contrast</td>
<td>All studies</td>
<td>63</td>
<td>1.15</td>
<td>1.08–1.23</td>
<td>0.00</td>
<td>54.4</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic White</td>
<td>19</td>
<td>1.09</td>
<td>0.97–1.22</td>
<td>0.03</td>
<td>42.5</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic Asian</td>
<td>3</td>
<td>1.18</td>
<td>0.85–1.64</td>
<td>0.16</td>
<td>46.4</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic White</td>
<td>15</td>
<td>1.05</td>
<td>0.98–1.13</td>
<td>0.69</td>
<td>0.0</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic Asian</td>
<td>27</td>
<td>1.30</td>
<td>1.15–1.46</td>
<td>0.00</td>
<td>69.3</td>
</tr>
<tr>
<td>Dominant model</td>
<td>All studies</td>
<td>63</td>
<td>1.18</td>
<td>1.07–1.31</td>
<td>0.00</td>
<td>49.3</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic White</td>
<td>19</td>
<td>1.06</td>
<td>0.95–1.18</td>
<td>0.15</td>
<td>25.1</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic Asian</td>
<td>3</td>
<td>0.95</td>
<td>0.59–1.52</td>
<td>0.51</td>
<td>0.0</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic White</td>
<td>15</td>
<td>1.09</td>
<td>0.98–1.20</td>
<td>0.17</td>
<td>26.3</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic Asian</td>
<td>27</td>
<td>1.37</td>
<td>1.10–1.69</td>
<td>0.00</td>
<td>64.4</td>
</tr>
<tr>
<td>Recessive model</td>
<td>All studies</td>
<td>63</td>
<td>1.18</td>
<td>1.08–1.30</td>
<td>0.00</td>
<td>45.0</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic White</td>
<td>19</td>
<td>1.09</td>
<td>0.96–1.23</td>
<td>0.05</td>
<td>37.6</td>
</tr>
<tr>
<td/>
<td>Type 1 diabetic Asian</td>
<td>3</td>
<td>1.00</td>
<td>0.61–1.64</td>
<td>0.21</td>
<td>35.5</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic White</td>
<td>15</td>
<td>1.05</td>
<td>0.93–1.18</td>
<td>0.61</td>
<td>0.0</td>
</tr>
<tr>
<td/>
<td>Type 2 diabetic Asian</td>
<td>27</td>
<td>1.34</td>
<td>1.15–1.56</td>
<td>0.00</td>
<td>60.9</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1470320311417655">
<label>*</label>
<p>Test for heterogeneity. A random-effects model was used when the <italic>p</italic>-value for heterogeneity test &lt; 0.05 and/or <italic>I</italic><sup>2</sup> &gt; 50%; otherwise, a fixed-effects model was used.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-1470320311417655" position="float">
<label>Figure 2.</label>
<caption>
<p>Odds ratios (log scale) of diabetic nephropathy associated with <italic>ACE</italic> I/D polymorphism for dominant genetic model. The graph shows individual and pooled estimates for all studies, and studies on type 1 diabetic Whites and Asians, as well as Whites and Asians with type 2 diabetes.</p>
</caption>
<graphic xlink:href="10.1177_1470320311417655-fig2.tif"/>
</fig>
<p>As shown in <xref ref-type="table" rid="table2-1470320311417655">Table 2</xref>, the overall analysis detected a significant association between the <italic>ACE</italic> I/D polymorphism and the risk of DN for all genetic models (ID versus II: OR = 1.12, 95% CI 1.02–1.24; DD versus II: OR = 1.27, 95% CI 1.13–1.44; allele contrast: OR = 1.15, 95% CI 1.08–1.23; dominant model: OR = 1.18, 95% CI 1.07–1.31; and recessive model: OR = 1.18, 95% CI 1.08–1.30, respectively).</p>
<p>In stratified analysis by ethnicity and diabetes mellitus type, we further found that the Asian group with T2DM showed a significant association for all genetic models (ID versus II: OR = 1.25, 95% CI 1.07–1.47; DD versus II: OR = 1.57, 95% CI 1.24–1.98; allele contrast: OR = 1.30, 95% CI 1.15–1.46; dominant model: OR = 1.37, 95% CI 1.10–1.69; and recessive model: OR = 1.34, 95% CI 1.15–1.56, respectively). However, we failed to find any significant effects for different genetic models in other subgroup. Further sensitivity analysis for HWE did not alter the pattern of results in both overall analysis and subgroup analysis.</p>
</sec>
<sec id="section10-1470320311417655">
<title>Source of heterogeneity and publication bias</title>
<p>As shown in <xref ref-type="table" rid="table2-1470320311417655">Table 2</xref>, heterogeneity between studies was observed in overall comparisons as well as subgroup analyses. We evaluated the source of heterogeneity in both dominant and recessive genetic models of the variant allele by ethnicity (Asian or White), DM type (T1DM or T2DM), HWE (in HWE or not) and study design (case–control, cross-sectional or cohort study design) by meta-regression analyses. It revealed that none of these five factors could explain significant between-study heterogeneity in genetic model for the polymorphism <italic>ACE</italic> I/D: ethnicity (<italic>p</italic> = 0.09), DM type (<italic>p</italic> = 0.77), HWE (<italic>p</italic> = 0.58) and study design (<italic>p</italic> = 0.82).</p>
<p>The potential presence of publication bias was evaluated using a funnel plot of the estimate of log-OR for the genotype DD versus II+ ID against the reciprocal of its standard error (<xref ref-type="fig" rid="fig3-1470320311417655">Figure 3</xref>). As is shown, no significant funnel asymmetry was observed which could indicate publication bias. We further used the Egger regression asymmetry test and the Begg adjusted rank correlation tests to access the publication bias of included literatures in the meta-analysis. As shown in <xref ref-type="table" rid="table3-1470320311417655">Table 3</xref>, no publication bias was observed for the polymorphism and risk of DN in the genetic model.</p>
<fig id="fig3-1470320311417655" position="float">
<label>Figure 3.</label>
<caption>
<p>Evaluation of publication bias using funnel plots. Plots are shown for all studies (A), subgroups involving type 1 diabetic Whites (B), and Whites and Asians with type 2 diabetes (C, D). No significant funnel asymmetry was observed which could indicate publication bias.</p>
</caption>
<graphic xlink:href="10.1177_1470320311417655-fig3.tif"/>
</fig>
<table-wrap id="table3-1470320311417655" position="float">
<label>Table 3.</label>
<caption>
<p>The results of the publication bias test in the dominant genetic model by Egger test and Begg test.</p>
</caption>
<graphic alternate-form-of="table3-1470320311417655" xlink:href="10.1177_1470320311417655-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Subgroup</th>
<th align="left">Egger test</th>
<th align="left">Begg test</th>
</tr>
</thead>
<tbody>
<tr>
<td>All studies</td>
<td>0.71</td>
<td>0.49</td>
</tr>
<tr>
<td>Type 1 diabetic White</td>
<td>0.98</td>
<td>0.18</td>
</tr>
<tr>
<td>Type 1 diabetic Asian</td>
<td>0.80</td>
<td>1.00</td>
</tr>
<tr>
<td>Type 2 diabetic White</td>
<td>0.98</td>
<td>0.20</td>
</tr>
<tr>
<td>Type 2 diabetic Asian</td>
<td>0.96</td>
<td>0.34</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="section11-1470320311417655" sec-type="discussion">
<title>Discussion</title>
<p>Why some diabetics develop nephropathy, whereas others do not, despite having a long-term hyperglycemia, remains an unresolved question. Because known environmental factors do not fully explain this, researchers have sought the answer in the genetic background of the host.<sup><xref ref-type="bibr" rid="bibr56-1470320311417655">56</xref></sup> The RAAS is a critical regulator of sodium balance, extracellular fluid volume, vascular resistance, and, ultimately, arterial blood pressure by angiotensin II. Thus, the RAAS serves as one of the most powerful regulators of arterial blood pressure and could be considered candidate genes involved in the pathogenesis of diabetic renal complication.<sup><xref ref-type="bibr" rid="bibr87-1470320311417655">87</xref></sup> The <italic>ACE</italic> is an important part of the RAAS, which is a complex regulatory network with intrinsic as well as extrinsic agonistic and antagonistic hormones. It had increasingly been recognized that <italic>ACE</italic> inhibition exert organ protective effects probably even beyond its antihypertensive potential in diabetic renal disease.<sup><xref ref-type="bibr" rid="bibr88-1470320311417655">88</xref>,<xref ref-type="bibr" rid="bibr89-1470320311417655">89</xref></sup> In 1990, Rigat et al.<sup><xref ref-type="bibr" rid="bibr19-1470320311417655">19</xref></sup> described the polymorphism of the <italic>ACE</italic> gene based on the presence (insertion I) or absence (deletion D) of a 278 base pair element in intron 16. Although the results of DNA gel-blot hybridization indicate that the insertion/deletion polymorphism is localized in the non-coding region (intron), it cannot exclude the possibility that as a result of different <italic>ACE</italic> pre-mRNA splicing, depending on the presence or absence of the insertion, part of this sequence might be present in the mature RNA, thus modifying its stability or giving rise to the presence of an additional peptide inside the protein, and consequently altering its secretion or stability. In addition, the insertion itself might modify the splicing process of the <italic>ACE</italic> precursor mRNA by interfering with the lariat formation step.<sup><xref ref-type="bibr" rid="bibr90-1470320311417655">90</xref></sup> This genotype accounts for 47% of the total phenotypic variance in plasma <italic>ACE</italic> levels in healthy individuals in a way that subjects with D alleles have an elevated activity.<sup><xref ref-type="bibr" rid="bibr19-1470320311417655">19</xref></sup> In addition Danser et al.<sup><xref ref-type="bibr" rid="bibr91-1470320311417655">91</xref></sup> showed that the <italic>ACE</italic> I/D polymorphism also influences <italic>ACE</italic> tissue concentrations. Numerous investigations into the potential role of <italic>ACE</italic> as a susceptibility gene for DN have been conducted over the past decades, with controversial results. Early meta-analyses attempted to reconcile these findings, but attempts to draw firm conclusions have been hindered by limited data, particularly when examining specific patient subgroups and increased relative studies.<sup><xref ref-type="bibr" rid="bibr92-1470320311417655">92</xref>-<xref ref-type="bibr" rid="bibr94-1470320311417655">94</xref></sup> From the present meta-analysis of 63 studies reported from 1994 to 2010 and comprising 26,580 subjects, we further found significant main effects and subgroup effects for <italic>ACE</italic> I/D polymorphism on DN risk, especially in the Asian group with T2DM.</p>
<p>Our meta-analysis examined the <italic>ACE</italic> I/D polymorphism and its relationship to susceptibility for DN. Its strength was based on the accumulation of published data giving greater information to detect significant differences. Non-English, non-indexed, and non-published studies in the literature were not reviewed, and this might introduce some bias.<sup><xref ref-type="bibr" rid="bibr95-1470320311417655">95</xref></sup> In this study, the effect of separate pairwise comparisons, allele contrast and the effects of the dominant and recessive genetic models were estimated. Subgroup analysis by ethnicity and DM type, and sensitivity for studies not in HWE, was performed. In addition, we further evaluated the source of heterogeneity and the publication bias of included literatures.</p>
<p>In the meta-analysis, only the unadjusted pooled ORs were calculated, because data for possible confounding factors that influence the estimates of associations (e.g. age, sex, body mass index [BMI]) were not provided. Sampling variability and stratification in genetic association studies could be a possible confounding factor on the role of genetic markers. In addition, the risk effect may depend on the interaction with other risk factors: smoking, alcohol consumption, exercise, control of diabetes, and BMI, all of which modulate the development of DN.<sup><xref ref-type="bibr" rid="bibr96-1470320311417655">96</xref>,<xref ref-type="bibr" rid="bibr97-1470320311417655">97</xref></sup> Furthermore, small numbers of individuals and inadequate information of lifestyle factors and dietary intake by the published studies limited our statistic power to fully investigate the gene–environment interactions. Therefore, further well-designed large studies, particularly referring to gene–gene and gene–environment interactions are warranted to confirm the real contribution of the <italic>ACE</italic> I/D polymorphism to DN susceptibility and might further elucidate the genetics of DN.</p>
<p>In summary, our present meta-analysis demonstrated that the <italic>ACE</italic> I/D polymorphism was associated with DN, especially in the Asian group with T2DM. <italic>ACE</italic> inhibitors are already widely used in the clinical management of DN. Studies have examined how the effect of these drugs on DN can be modulated by genetic variation at the <italic>ACE</italic> locus. Several studies have indicated that the DD genotype could be associated with better response to the anti-proteinuric effect of <italic>ACE</italic> inhibitors in patients with DN. Our present analysis not only might help us to further explore whether and how the <italic>ACE</italic> I/D polymorphism mutation play its own role in the development of DN, but also help us to make more effectively targeted use of <italic>ACE</italic> inhibitors in the clinical management of DN.</p>
</sec>
</body>
<back>
<ack><p>The authors would like to gratefully acknowledge the most helpful comments on this paper received from Professor Yong Gu, Division of Nephrology, Huashan Hospital and Institute of Nephrology, Fudan University, China.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This research received no specific grant from any funding age in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare that they have no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320311417655">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S</given-names></name>
<name><surname>Mitu</surname><given-names>GM</given-names></name>
<name><surname>Hirschberg</surname><given-names>R</given-names></name>
</person-group>. <article-title>Osmotic polyuria: an overlooked mechanism in diabetic nephropathy</article-title>. <source>Nephrol Dial Transplant</source> <year>2008</year>; <volume>23</volume>: <fpage>2167</fpage>–<lpage>2172</lpage>.</citation>
</ref>
<ref id="bibr2-1470320311417655">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ritz</surname><given-names>E</given-names></name>
<name><surname>Rychlik</surname><given-names>I</given-names></name>
<name><surname>Locatelli</surname><given-names>F</given-names></name>
<name><surname>Halimi</surname><given-names>S</given-names></name>
</person-group>. <article-title>End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions</article-title>. <source>Am J Kidney Dis</source> <year>1999</year>; <volume>34</volume>: <fpage>795</fpage>–<lpage>808</lpage>.</citation>
</ref>
<ref id="bibr3-1470320311417655">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adler</surname><given-names>AI</given-names></name>
<name><surname>Stevens</surname><given-names>RJ</given-names></name>
<name><surname>Manley</surname><given-names>SE</given-names></name>
<name><surname>Bilous</surname><given-names>RW</given-names></name>
<name><surname>Cull</surname><given-names>CA</given-names></name>
<name><surname>Holman</surname><given-names>RR</given-names></name>
</person-group>. <article-title>Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)</article-title>. <source>Kidney Int</source> <year>2003</year>; <volume>63</volume>: <fpage>225</fpage>–<lpage>232</lpage>.</citation>
</ref>
<ref id="bibr4-1470320311417655">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hovind</surname><given-names>P</given-names></name>
<name><surname>Rossing</surname><given-names>P</given-names></name>
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Smidt</surname><given-names>UM</given-names></name>
<name><surname>Parving</surname><given-names>HH</given-names></name>
</person-group>. <article-title>Progression of diabetic nephropathy</article-title>. <source>Kidney Int</source> <year>2001</year>; <volume>59</volume>: <fpage>702</fpage>–<lpage>709</lpage>.</citation>
</ref>
<ref id="bibr5-1470320311417655">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobsen</surname><given-names>P</given-names></name>
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Carstensen</surname><given-names>B</given-names></name>
<name><surname>Hovind</surname><given-names>P</given-names></name>
<name><surname>Poirier</surname><given-names>O</given-names></name>
<name><surname>Parving</surname><given-names>HH</given-names></name>
</person-group>. <article-title>Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy</article-title>. <source>J Am Soc Nephrol</source> <year>2003</year>; <volume>14</volume>: <fpage>2843</fpage>–<lpage>2850</lpage>.</citation>
</ref>
<ref id="bibr6-1470320311417655">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parving</surname><given-names>HH</given-names></name>
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Rossing</surname><given-names>P</given-names></name>
</person-group>. <article-title>Genetics of diabetic nephropathy</article-title>. <source>J Am Soc Nephrol</source> <year>1996</year>; <volume>7</volume>: <fpage>2509</fpage>–<lpage>2517</lpage>.</citation>
</ref>
<ref id="bibr7-1470320311417655">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borch-Johnsen</surname><given-names>K</given-names></name>
<name><surname>Norgaard</surname><given-names>K</given-names></name>
<name><surname>Hommel</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Is diabetic nephropathy an inherited complication?</article-title> <source>Kidney Int</source> <year>1992</year>; <volume>41</volume>: <fpage>719</fpage>–<lpage>722</lpage>.</citation>
</ref>
<ref id="bibr8-1470320311417655">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quinn</surname><given-names>M</given-names></name>
<name><surname>Angelico</surname><given-names>MC</given-names></name>
<name><surname>Warram</surname><given-names>JH</given-names></name>
<name><surname>Krolewski</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Familial factors determine the development of diabetic nephropathy in patients with IDDM</article-title>. <source>Diabetologia</source> <year>1996</year>; <volume>39</volume>: <fpage>940</fpage>–<lpage>945</lpage>.</citation>
</ref>
<ref id="bibr9-1470320311417655">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strojek</surname><given-names>K</given-names></name>
<name><surname>Grzeszczak</surname><given-names>W</given-names></name>
<name><surname>Morawin</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Nephropathy of type II diabetes: evidence for hereditary factors?</article-title> <source>Kidney Int</source> <year>1997</year>; <volume>51</volume>: <fpage>1602</fpage>–<lpage>1607</lpage>.</citation>
</ref>
<ref id="bibr10-1470320311417655">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zintzaras</surname><given-names>E</given-names></name>
<name><surname>Stefanidis</surname><given-names>I</given-names></name>
</person-group>. <article-title>Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis</article-title>. <source>J Hum Genet</source> <year>2005</year>; <volume>50</volume>: <fpage>84</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr11-1470320311417655">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zintzaras</surname><given-names>E</given-names></name>
<name><surname>Uhlig</surname><given-names>K</given-names></name>
<name><surname>Koukoulis</surname><given-names>GN</given-names></name>
<name><surname>Papathanasiou</surname><given-names>AA</given-names></name>
<name><surname>Stefanidis</surname><given-names>I</given-names></name>
</person-group>. <article-title>Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis</article-title>. <source>J Hum Genet</source> <year>2007</year>; <volume>52</volume>: <fpage>881</fpage>–<lpage>890</lpage>.</citation>
</ref>
<ref id="bibr12-1470320311417655">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shpichinetsky</surname><given-names>V</given-names></name>
<name><surname>Raz</surname><given-names>I</given-names></name>
<name><surname>Friedlander</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients</article-title>. <source>J Nutr</source> <year>2000</year>; <volume>130</volume>: <fpage>2493</fpage>–<lpage>2497</lpage>.</citation>
</ref>
<ref id="bibr13-1470320311417655">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>S</given-names></name>
<name><surname>Ritz</surname><given-names>E</given-names></name>
</person-group>. <article-title>Genetics of the renin–angiotensin system and renal disease: a progress report</article-title>. <source>Curr Opin Nephrol Hypertens</source> <year>1997</year>; <volume>6</volume>: <fpage>146</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr14-1470320311417655">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burns</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Angiotensin II and its receptors in the diabetic kidney</article-title>. <source>Am J Kidney Dis</source> <year>2000</year>; <volume>36</volume>: <fpage>449</fpage>–<lpage>467</lpage>.</citation>
</ref>
<ref id="bibr15-1470320311417655">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S</given-names></name>
<name><surname>Iwao</surname><given-names>H</given-names></name>
</person-group>. <article-title>Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases</article-title>. <source>Pharmacol Rev</source> <year>2000</year>; <volume>52</volume>: <fpage>11</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr16-1470320311417655">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rudberg</surname><given-names>S</given-names></name>
<name><surname>Aperia</surname><given-names>A</given-names></name>
<name><surname>Freyschuss</surname><given-names>U</given-names></name>
<name><surname>Persson</surname><given-names>B</given-names></name>
</person-group>. <article-title>Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect</article-title>. <source>Diabetologia</source> <year>1990</year>; <volume>33</volume>: <fpage>470</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr17-1470320311417655">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tiret</surname><given-names>L</given-names></name>
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Visvikis</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels</article-title>. <source>Am J Hum Genet</source> <year>1992</year>; <volume>51</volume>: <fpage>197</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr18-1470320311417655">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crisan</surname><given-names>D</given-names></name>
<name><surname>Carr</surname><given-names>J</given-names></name>
</person-group>. <article-title>Angiotensin I-converting enzyme: genotype and disease associations</article-title>. <source>J Mol Diagn</source> <year>2000</year>; <volume>2</volume>: <fpage>105</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr19-1470320311417655">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Hubert</surname><given-names>C</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name>
<name><surname>Cambien</surname><given-names>F</given-names></name>
<name><surname>Corvol</surname><given-names>P</given-names></name>
<name><surname>Soubrier</surname><given-names>F</given-names></name>
</person-group>. <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title>. <source>J Clin Invest</source> <year>1990</year>; <volume>86</volume>: <fpage>1343</fpage>–<lpage>1346</lpage>.</citation>
</ref>
<ref id="bibr20-1470320311417655">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doria</surname><given-names>A</given-names></name>
<name><surname>Warram</surname><given-names>JH</given-names></name>
<name><surname>Krolewski</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene</article-title>. <source>Diabetes</source> <year>1994</year>; <volume>43</volume>: <fpage>690</fpage>–<lpage>695</lpage>.</citation>
</ref>
<ref id="bibr21-1470320311417655">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Powrie</surname><given-names>JK</given-names></name>
<name><surname>Watts</surname><given-names>GF</given-names></name>
<name><surname>Ingham</surname><given-names>JN</given-names></name>
<name><surname>Taub</surname><given-names>NA</given-names></name>
<name><surname>Talmud</surname><given-names>PJ</given-names></name>
<name><surname>Shaw</surname><given-names>KM</given-names></name>
</person-group>. <article-title>Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes</article-title>. <source>BMJ</source> <year>1994</year>; <volume>309</volume>: <fpage>1608</fpage>–<lpage>1612</lpage>.</citation>
</ref>
<ref id="bibr22-1470320311417655">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dudley</surname><given-names>CR</given-names></name>
<name><surname>Keavney</surname><given-names>B</given-names></name>
<name><surname>Stratton</surname><given-names>IM</given-names></name>
<name><surname>Turner</surname><given-names>RC</given-names></name>
<name><surname>Ratcliffe</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>U.K. Prospective Diabetes Study. XV: Relationship of renin–angiotensin system gene polymorphisms with microalbuminuria in NIDDM</article-title>. <source>Kidney Int</source> <year>1995</year>; <volume>48</volume>: <fpage>1907</fpage>–<lpage>1911</lpage>.</citation>
</ref>
<ref id="bibr23-1470320311417655">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujisawa</surname><given-names>T</given-names></name>
<name><surname>Ikegami</surname><given-names>H</given-names></name>
<name><surname>Shen</surname><given-names>GQ</given-names></name><etal/>
</person-group>. <article-title>Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM</article-title>. <source>Diabetes Care</source> <year>1995</year>; <volume>18</volume>: <fpage>983</fpage>–<lpage>985</lpage>.</citation>
</ref>
<ref id="bibr24-1470320311417655">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mizuiri</surname><given-names>S</given-names></name>
<name><surname>Hemmi</surname><given-names>H</given-names></name>
<name><surname>Inoue</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus</article-title>. <source>Nephron</source> <year>1995</year>; <volume>70</volume>: <fpage>455</fpage>–<lpage>459</lpage>.</citation>
</ref>
<ref id="bibr25-1470320311417655">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Panagiotopoulos</surname><given-names>S</given-names></name>
<name><surname>Smith</surname><given-names>TJ</given-names></name>
<name><surname>Aldred</surname><given-names>GP</given-names></name>
<name><surname>Baker</surname><given-names>EJ</given-names></name>
<name><surname>Jacklin</surname><given-names>CJ</given-names></name>
<name><surname>Jerums</surname><given-names>G</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate</article-title>. <source>J Diabetes Complications</source> <year>1995</year>; <volume>9</volume>: <fpage>272</fpage>–<lpage>276</lpage>.</citation>
</ref>
<ref id="bibr26-1470320311417655">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>S</given-names></name>
<name><surname>Schone</surname><given-names>N</given-names></name>
<name><surname>Ritz</surname><given-names>E</given-names></name>
</person-group>. <article-title>Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group</article-title>. <source>Kidney Int</source> <year>1995</year>; <volume>47</volume>: <fpage>1176</fpage>–<lpage>1181</lpage>.</citation>
</ref>
<ref id="bibr27-1470320311417655">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Cambien</surname><given-names>F</given-names></name>
<name><surname>Rossing</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients</article-title>. <source>Diabetes</source> <year>1995</year>; <volume>44</volume>: <fpage>489</fpage>–<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr28-1470320311417655">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chowdhury</surname><given-names>TA</given-names></name>
<name><surname>Dronsfield</surname><given-names>MJ</given-names></name>
<name><surname>Kumar</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Examination of two genetic polymorphisms within the renin–angiotensin system: no evidence for an association with nephropathy in IDDM</article-title>. <source>Diabetologia</source> <year>1996</year>; <volume>39</volume>: <fpage>1108</fpage>–<lpage>1114</lpage>.</citation>
</ref>
<ref id="bibr29-1470320311417655">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doi</surname><given-names>Y</given-names></name>
<name><surname>Yoshizumi</surname><given-names>H</given-names></name>
<name><surname>Yoshinari</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM</article-title>. <source>Diabetologia</source> <year>1996</year>; <volume>39</volume>: <fpage>97</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr30-1470320311417655">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakajima</surname><given-names>S</given-names></name>
<name><surname>Baba</surname><given-names>T</given-names></name>
<name><surname>Yajima</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients?</article-title> <source>Diabetes Care</source> <year>1996</year>; <volume>19</volume>: <fpage>1420</fpage>–<lpage>1422</lpage>.</citation>
</ref>
<ref id="bibr31-1470320311417655">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oh</surname><given-names>TG</given-names></name>
<name><surname>Shin</surname><given-names>CS</given-names></name>
<name><surname>Park</surname><given-names>KS</given-names></name><etal/>
</person-group>. <article-title>Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients</article-title>. <source>Korean J Intern Med</source> <year>1996</year>; <volume>11</volume>: <fpage>133</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr32-1470320311417655">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohno</surname><given-names>T</given-names></name>
<name><surname>Kawazu</surname><given-names>S</given-names></name>
<name><surname>Tomono</surname><given-names>S</given-names></name>
</person-group>. <article-title>Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics</article-title>. <source>Metabolism</source> <year>1996</year>; <volume>45</volume>: <fpage>218</fpage>–<lpage>222</lpage>.</citation>
</ref>
<ref id="bibr33-1470320311417655">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshida</surname><given-names>H</given-names></name>
<name><surname>Kuriyama</surname><given-names>S</given-names></name>
<name><surname>Atsumi</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus</article-title>. <source>Kidney Int</source> <year>1996</year>; <volume>50</volume>: <fpage>657</fpage>–<lpage>664</lpage>.</citation>
</ref>
<ref id="bibr34-1470320311417655">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnas</surname><given-names>U</given-names></name>
<name><surname>Schmidt</surname><given-names>A</given-names></name>
<name><surname>Illievich</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control</article-title>. <source>Diabetologia</source> <year>1997</year>; <volume>40</volume>: <fpage>327</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr35-1470320311417655">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hibberd</surname><given-names>ML</given-names></name>
<name><surname>Millward</surname><given-names>BA</given-names></name>
<name><surname>Demaine</surname><given-names>AG</given-names></name>
</person-group>. <article-title>The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes</article-title>. <source>J Diabetes Complications</source> <year>1997</year>; <volume>11</volume>: <fpage>2</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr36-1470320311417655">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jeffers</surname><given-names>BW</given-names></name>
<name><surname>Estacio</surname><given-names>RO</given-names></name>
<name><surname>Raynolds</surname><given-names>MV</given-names></name>
<name><surname>Schrier</surname><given-names>RW</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy</article-title>. <source>Kidney Int</source> <year>1997</year>; <volume>52</volume>: <fpage>473</fpage>–<lpage>477</lpage>.</citation>
</ref>
<ref id="bibr37-1470320311417655">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marre</surname><given-names>M</given-names></name>
<name><surname>Jeunemaitre</surname><given-names>X</given-names></name>
<name><surname>Gallois</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Contribution of genetic polymorphism in the renin–angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group</article-title>. <source>J Clin Invest</source> <year>1997</year>; <volume>99</volume>: <fpage>1585</fpage>–<lpage>1595</lpage>.</citation>
</ref>
<ref id="bibr38-1470320311417655">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ringel</surname><given-names>J</given-names></name>
<name><surname>Beige</surname><given-names>J</given-names></name>
<name><surname>Kunz</surname><given-names>R</given-names></name>
<name><surname>Distler</surname><given-names>A</given-names></name>
<name><surname>Sharma</surname><given-names>AM</given-names></name>
</person-group>. <article-title>Genetic variants of the renin–angiotensin system, diabetic nephropathy and hypertension</article-title>. <source>Diabetologia</source> <year>1997</year>; <volume>40</volume>: <fpage>193</fpage>–<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr39-1470320311417655">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Demurov</surname><given-names>LM</given-names></name>
<name><surname>Chistiakov</surname><given-names>DA</given-names></name>
<name><surname>Chugunova</surname><given-names>LA</given-names></name><etal/>
</person-group>. <article-title>Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications</article-title>. <source>Mol Biol (Mosk)</source> <year>1997</year>; <volume>31</volume>: <fpage>59</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr40-1470320311417655">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>S</given-names></name>
<name><surname>Ritz</surname><given-names>E</given-names></name>
</person-group>. <article-title>Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes</article-title>. <source>Nephrol Dial Transplant</source> <year>1997</year>; <volume>12</volume>(<supplement>Suppl. 2</supplement>): <fpage>37</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr41-1470320311417655">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gutierrez</surname><given-names>C</given-names></name>
<name><surname>Vendrell</surname><given-names>J</given-names></name>
<name><surname>Pastor</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population</article-title>. <source>Metabolism</source> <year>1997</year>; <volume>46</volume>: <fpage>976</fpage>–<lpage>980</lpage>.</citation>
</ref>
<ref id="bibr42-1470320311417655">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pfohl</surname><given-names>M</given-names></name>
<name><surname>Frost</surname><given-names>D</given-names></name>
<name><surname>Koch</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients</article-title>. <source>Horm Metab Res</source> <year>1998</year>; <volume>30</volume>: <fpage>276</fpage>–<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr43-1470320311417655">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freire</surname><given-names>MB</given-names></name>
<name><surname>van Dijk</surname><given-names>DJ</given-names></name>
<name><surname>Erman</surname><given-names>A</given-names></name>
<name><surname>Boner</surname><given-names>G</given-names></name>
<name><surname>Warram</surname><given-names>JH</given-names></name>
<name><surname>Krolewski</surname><given-names>AS</given-names></name>
</person-group>. <article-title>DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus</article-title>. <source>Nephrol Dial Transplant</source> <year>1998</year>; <volume>13</volume>: <fpage>2553</fpage>–<lpage>2558</lpage>.</citation>
</ref>
<ref id="bibr44-1470320311417655">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grzeszczak</surname><given-names>W</given-names></name>
<name><surname>Zychma</surname><given-names>MJ</given-names></name>
<name><surname>Lacka</surname><given-names>B</given-names></name>
<name><surname>Zukowska-Szczechowska</surname><given-names>E</given-names></name>
</person-group>. <article-title>Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus</article-title>. <source>J Am Soc Nephrol</source> <year>1998</year>; <volume>9</volume>: <fpage>1664</fpage>–<lpage>1669</lpage>.</citation>
</ref>
<ref id="bibr45-1470320311417655">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hanyu</surname><given-names>O</given-names></name>
<name><surname>Hanawa</surname><given-names>H</given-names></name>
<name><surname>Nakagawa</surname><given-names>O</given-names></name><etal/>
</person-group>. <article-title>Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy</article-title>. <source>Ren Fail</source> <year>1998</year>; <volume>20</volume>: <fpage>125</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr46-1470320311417655">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>XH</given-names></name>
<name><surname>Rantalaiho</surname><given-names>V</given-names></name>
<name><surname>Wirta</surname><given-names>O</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years</article-title>. <source>Nephron</source> <year>1998</year>; <volume>80</volume>: <fpage>17</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr47-1470320311417655">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Xiang</surname><given-names>K</given-names></name>
<name><surname>Weng</surname><given-names>Q</given-names></name><etal/>
</person-group>. <article-title>Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy</article-title>. <source>Chin Med J (Engl)</source> <year>1998</year>; <volume>111</volume>: <fpage>478</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr48-1470320311417655">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bouhanick</surname><given-names>B</given-names></name>
<name><surname>Gallois</surname><given-names>Y</given-names></name>
<name><surname>Hadjadj</surname><given-names>S</given-names></name>
<name><surname>Boux</surname><given-names>de</given-names></name>
<name><surname>Casson</surname><given-names>F</given-names></name>
<name><surname>Limal</surname><given-names>JM</given-names></name>
<name><surname>Marre</surname><given-names>M</given-names></name>
</person-group>. <article-title>Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents</article-title>. <source>Diabetes Care</source> <year>1999</year>; <volume>22</volume>: <fpage>618</fpage>–<lpage>622</lpage>.</citation>
</ref>
<ref id="bibr49-1470320311417655">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Cosmo</surname><given-names>S</given-names></name>
<name><surname>Margaglione</surname><given-names>M</given-names></name>
<name><surname>Tassi</surname><given-names>V</given-names></name><etal/>
</person-group>. <article-title>ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes</article-title>. <source>Diabetes Metab Res Rev</source> <year>1999</year>; <volume>15</volume>: <fpage>247</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr50-1470320311417655">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuramoto</surname><given-names>N</given-names></name>
<name><surname>Iizuka</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance</article-title>. <source>Am J Kidney Dis</source> <year>1999</year>; <volume>33</volume>: <fpage>276</fpage>–<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr51-1470320311417655">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miura</surname><given-names>J</given-names></name>
<name><surname>Uchigata</surname><given-names>Y</given-names></name>
<name><surname>Yokoyama</surname><given-names>H</given-names></name>
<name><surname>Omori</surname><given-names>Y</given-names></name>
<name><surname>Iwamoto</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Genetic polymorphism of renin–angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus</article-title>. <source>Diabetes Res Clin Pract</source> <year>1999</year>; <volume>45</volume>: <fpage>41</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr52-1470320311417655">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vleming</surname><given-names>LJ</given-names></name>
<name><surname>van der Pijl</surname><given-names>JW</given-names></name>
<name><surname>Lemkes</surname><given-names>HH</given-names></name><etal/>
</person-group>. <article-title>The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM</article-title>. <source>Clin Nephrol</source> <year>1999</year>; <volume>51</volume>: <fpage>133</fpage>–<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr53-1470320311417655">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname><given-names>TY</given-names></name>
<name><surname>Chan</surname><given-names>JC</given-names></name>
<name><surname>Poon</surname><given-names>E</given-names></name>
<name><surname>Li</surname><given-names>PK</given-names></name>
</person-group>. <article-title>Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes</article-title>. <source>Am J Kidney Dis</source> <year>1999</year>; <volume>33</volume>: <fpage>1064</fpage>–<lpage>1070</lpage>.</citation>
</ref>
<ref id="bibr54-1470320311417655">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tomino</surname><given-names>Y</given-names></name>
<name><surname>Makita</surname><given-names>Y</given-names></name>
<name><surname>Shike</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients</article-title>. <source>Nephron</source> <year>1999</year>; <volume>82</volume>: <fpage>139</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr55-1470320311417655">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>MC</given-names></name>
<name><surname>Lin</surname><given-names>SR</given-names></name>
<name><surname>Hsieh</surname><given-names>TJ</given-names></name><etal/>
</person-group>. <article-title>Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan</article-title>. <source>Nephrol Dial Transplant</source> <year>2000</year>; <volume>15</volume>: <fpage>1008</fpage>–<lpage>1013</lpage>.</citation>
</ref>
<ref id="bibr56-1470320311417655">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Ittersum</surname><given-names>FJ</given-names></name>
<name><surname>de Man</surname><given-names>AM</given-names></name>
<name><surname>Thijssen</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Genetic polymorphisms of the renin–angiotensin system and complications of insulin-dependent diabetes mellitus</article-title>. <source>Nephrol Dial Transplant</source> <year>2000</year>; <volume>15</volume>: <fpage>1000</fpage>–<lpage>1007</lpage>.</citation>
</ref>
<ref id="bibr57-1470320311417655">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Araz</surname><given-names>M</given-names></name>
<name><surname>Yilmaz</surname><given-names>N</given-names></name>
<name><surname>Gungor</surname><given-names>K</given-names></name>
<name><surname>Okan</surname><given-names>V</given-names></name>
<name><surname>Kepekci</surname><given-names>Y</given-names></name>
<name><surname>Sukru Aynacioglu</surname><given-names>A</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients</article-title>. <source>Diabetes Res Clin Pract</source> <year>2001</year>; <volume>54</volume>: <fpage>95</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr58-1470320311417655">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Azar</surname><given-names>ST</given-names></name>
<name><surname>Zalloua</surname><given-names>PA</given-names></name>
<name><surname>Medlej</surname><given-names>R</given-names></name>
<name><surname>Halabi</surname><given-names>G</given-names></name>
</person-group>. <article-title>The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics</article-title>. <source>Endocr Res</source> <year>2001</year>; <volume>27</volume>: <fpage>99</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr59-1470320311417655">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gohda</surname><given-names>T</given-names></name>
<name><surname>Makita</surname><given-names>Y</given-names></name>
<name><surname>Shike</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Association of the DD genotype and development of Japanese type 2 diabetic nephropathy</article-title>. <source>Clin Nephrol</source> <year>2001</year>; <volume>56</volume>: <fpage>475</fpage>–<lpage>480</lpage>.</citation>
</ref>
<ref id="bibr60-1470320311417655">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taniwaki</surname><given-names>H</given-names></name>
<name><surname>Ishimura</surname><given-names>E</given-names></name>
<name><surname>Matsumoto</surname><given-names>N</given-names></name>
<name><surname>Emoto</surname><given-names>M</given-names></name>
<name><surname>Inaba</surname><given-names>M</given-names></name>
<name><surname>Nishizawa</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy</article-title>. <source>Diabetes Care</source> <year>2001</year>; <volume>24</volume>: <fpage>1653</fpage>–<lpage>1660</lpage>.</citation>
</ref>
<ref id="bibr61-1470320311417655">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Viswanathan</surname><given-names>V</given-names></name>
<name><surname>Zhu</surname><given-names>Y</given-names></name>
<name><surname>Bala</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients</article-title>. <source>JOP</source> <year>2001</year>; <volume>2</volume>: <fpage>83</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr62-1470320311417655">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fradin</surname><given-names>S</given-names></name>
<name><surname>Goulet-Salmon</surname><given-names>B</given-names></name>
<name><surname>Chantepie</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Relationship between polymorphisms in the renin–angiotensin system and nephropathy in type 2 diabetic patients</article-title>. <source>Diabetes Metab</source> <year>2002</year>; <volume>28</volume>: <fpage>27</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr63-1470320311417655">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>YJ</given-names></name>
<name><surname>Tsai</surname><given-names>JC</given-names></name>
</person-group>. <article-title>ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients</article-title>. <source>Diabetes Care</source> <year>2002</year>; <volume>25</volume>: <fpage>1002</fpage>–<lpage>1008</lpage>.</citation>
</ref>
<ref id="bibr64-1470320311417655">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ha</surname><given-names>SK</given-names></name>
<name><surname>Park</surname><given-names>HC</given-names></name>
<name><surname>Park</surname><given-names>HS</given-names></name><etal/>
</person-group>. <article-title>ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy</article-title>. <source>Am J Kidney Dis</source> <year>2003</year>; <volume>41</volume>: <fpage>943</fpage>–<lpage>949</lpage>.</citation>
</ref>
<ref id="bibr65-1470320311417655">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hadjadj</surname><given-names>S</given-names></name>
<name><surname>Gallois</surname><given-names>Y</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients</article-title>. <source>Diabet Med</source> <year>2003</year>; <volume>20</volume>: <fpage>677</fpage>–<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr66-1470320311417655">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okuno</surname><given-names>S</given-names></name>
<name><surname>Utsugi</surname><given-names>T</given-names></name>
<name><surname>Ohno</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study</article-title>. <source>J Int Med Res</source> <year>2003</year>; <volume>31</volume>: <fpage>290</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr67-1470320311417655">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>HR</given-names></name>
<name><surname>Cheng</surname><given-names>CH</given-names></name>
<name><surname>Shu</surname><given-names>KH</given-names></name>
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Lian</surname><given-names>JD</given-names></name>
<name><surname>Wu</surname><given-names>MY</given-names></name>
</person-group>. <article-title>Study of the polymorphism of angiotensinogen, angiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan</article-title>. <source>J Chin Med Assoc</source> <year>2003</year>; <volume>66</volume>: <fpage>51</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr68-1470320311417655">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arzu Ergen</surname><given-names>H</given-names></name>
<name><surname>Hatemi</surname><given-names>H</given-names></name>
<name><surname>Agachan</surname><given-names>B</given-names></name>
<name><surname>Camlica</surname><given-names>H</given-names></name>
<name><surname>Isbir</surname><given-names>T</given-names></name>
</person-group>. <article-title>Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients</article-title>. <source>Exp Mol Med</source> <year>2004</year>; <volume>36</volume>: <fpage>345</fpage>–<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr69-1470320311417655">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>HC</given-names></name>
<name><surname>Choi</surname><given-names>SR</given-names></name>
<name><surname>Kim</surname><given-names>BS</given-names></name><etal/>
</person-group>. <article-title>Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients</article-title>. <source>Yonsei Med J</source> <year>2005</year>; <volume>46</volume>: <fpage>779</fpage>–<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr70-1470320311417655">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Canani</surname><given-names>LH</given-names></name>
<name><surname>Costa</surname><given-names>LA</given-names></name>
<name><surname>Crispim</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes</article-title>. <source>Diabet Med</source> <year>2005</year>; <volume>22</volume>: <fpage>1167</fpage>–<lpage>1172</lpage>.</citation>
</ref>
<ref id="bibr71-1470320311417655">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prasad</surname><given-names>P</given-names></name>
<name><surname>Tiwari</surname><given-names>AK</given-names></name>
<name><surname>Kumar</surname><given-names>KM</given-names></name><etal/>
</person-group>. <article-title>Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms</article-title>. <source>BMC Med Genet</source> <year>2006</year>; <volume>7</volume>: <fpage>42</fpage>.</citation>
</ref>
<ref id="bibr72-1470320311417655">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buraczynska</surname><given-names>M</given-names></name>
<name><surname>Ksiazek</surname><given-names>P</given-names></name>
<name><surname>Drop</surname><given-names>A</given-names></name>
<name><surname>Zaluska</surname><given-names>W</given-names></name>
<name><surname>Spasiewicz</surname><given-names>D</given-names></name>
<name><surname>Ksiazek</surname><given-names>A</given-names></name>
</person-group>. <article-title>Genetic polymorphisms of the renin–angiotensin system in end-stage renal disease</article-title>. <source>Nephrol Dial Transplant</source> <year>2006</year>; <volume>21</volume>: <fpage>979</fpage>–<lpage>983</lpage>.</citation>
</ref>
<ref id="bibr73-1470320311417655">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>So</surname><given-names>WY</given-names></name>
<name><surname>Ma</surname><given-names>RC</given-names></name>
<name><surname>Ozaki</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients– interaction with ACE insertion/deletion polymorphism</article-title>. <source>Kidney Int</source> <year>2006</year>; <volume>69</volume>: <fpage>1438</fpage>–<lpage>1443</lpage>.</citation>
</ref>
<ref id="bibr74-1470320311417655">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Osawa</surname><given-names>N</given-names></name>
<name><surname>Koya</surname><given-names>D</given-names></name>
<name><surname>Araki</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Combinational effect of genes for the renin–angiotensin system in conferring susceptibility to diabetic nephropathy</article-title>. <source>J Hum Genet</source> <year>2007</year>; <volume>52</volume>: <fpage>143</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr75-1470320311417655">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hadjadj</surname><given-names>S</given-names></name>
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Forsblom</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations</article-title>. <source>J Am Soc Nephrol</source> <year>2007</year>; <volume>18</volume>: <fpage>1284</fpage>–<lpage>1291</lpage>.</citation>
</ref>
<ref id="bibr76-1470320311417655">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Movva</surname><given-names>S</given-names></name>
<name><surname>Alluri</surname><given-names>RV</given-names></name>
<name><surname>Komandur</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians</article-title>. <source>J Diabetes Complications</source> <year>2007</year>; <volume>21</volume>: <fpage>237</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr77-1470320311417655">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mollsten</surname><given-names>A</given-names></name>
<name><surname>Kockum</surname><given-names>I</given-names></name>
<name><surname>Svensson</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>The effect of polymorphisms in the renin–angiotensin-aldosterone system on diabetic nephropathy risk</article-title>. <source>J Diabetes Complications</source> <year>2008</year>; <volume>22</volume>: <fpage>377</fpage>–<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr78-1470320311417655">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gallego</surname><given-names>PH</given-names></name>
<name><surname>Shephard</surname><given-names>N</given-names></name>
<name><surname>Bulsara</surname><given-names>MK</given-names></name><etal/>
</person-group>. <article-title>Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus</article-title>. <source>J Diabetes Complications</source> <year>2008</year>; <volume>22</volume>: <fpage>191</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr79-1470320311417655">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eroglu</surname><given-names>Z</given-names></name>
<name><surname>Cetinkalp</surname><given-names>S</given-names></name>
<name><surname>Erdogan</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy</article-title>. <source>J Diabetes Complications</source> <year>2008</year>; <volume>22</volume>: <fpage>186</fpage>–<lpage>190</lpage>.</citation>
</ref>
<ref id="bibr80-1470320311417655">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tien</surname><given-names>KJ</given-names></name>
<name><surname>Hsiao</surname><given-names>JY</given-names></name>
<name><surname>Hsu</surname><given-names>SC</given-names></name><etal/>
</person-group>. <article-title>Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes</article-title>. <source>Am J Nephrol</source> <year>2009</year>; <volume>29</volume>: <fpage>299</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr81-1470320311417655">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahluwalia</surname><given-names>TS</given-names></name>
<name><surname>Ahuja</surname><given-names>M</given-names></name>
<name><surname>Rai</surname><given-names>TS</given-names></name><etal/>
</person-group>. <article-title>ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy</article-title>. <source>DNA Cell Biol</source> <year>2009</year>; <volume>28</volume>: <fpage>141</fpage>–<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr82-1470320311417655">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jayapalan</surname><given-names>JJ</given-names></name>
<name><surname>Muniandy</surname><given-names>S</given-names></name>
<name><surname>Chan</surname><given-names>SP</given-names></name>
</person-group>. <article-title>Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects</article-title>. <source>Indian J Hum Genet</source> <volume>16</volume>: <fpage>78</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr83-1470320311417655">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zintzaras</surname><given-names>E</given-names></name>
<name><surname>Lau</surname><given-names>J</given-names></name>
</person-group>. <article-title>Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches</article-title>. <source>J Clin Epidemiol</source> <year>2008</year>; <volume>61</volume>: <fpage>634</fpage>–<lpage>645</lpage>.</citation>
</ref>
<ref id="bibr84-1470320311417655">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>JP</given-names></name>
<name><surname>Thompson</surname><given-names>SG</given-names></name>
</person-group>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <year>2002</year>; <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</citation>
</ref>
<ref id="bibr85-1470320311417655">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egger</surname><given-names>M</given-names></name>
<name><surname>Davey Smith</surname><given-names>G</given-names></name>
<name><surname>Schneider</surname><given-names>M</given-names></name>
<name><surname>Minder</surname><given-names>C</given-names></name>
</person-group>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <year>1997</year>; <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr86-1470320311417655">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Begg</surname><given-names>CB</given-names></name>
<name><surname>Mazumdar</surname><given-names>M</given-names></name>
</person-group>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <year>1994</year>; <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</citation>
</ref>
<ref id="bibr87-1470320311417655">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harrison-Bernard</surname><given-names>LM</given-names></name>
</person-group>. <article-title>The renal renin–angiotensin system</article-title>. <source>Adv Physiol Educ</source> <year>2009</year>; <volume>33</volume>: <fpage>270</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr88-1470320311417655">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brenner</surname><given-names>BM</given-names></name>
<name><surname>Cooper</surname><given-names>ME</given-names></name>
<name><surname>de Zeeuw</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy</article-title>. <source>N Engl J Med</source> <year>2001</year>; <volume>345</volume>: <fpage>861</fpage>–<lpage>869</lpage>.</citation>
</ref>
<ref id="bibr89-1470320311417655">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>EJ</given-names></name>
<name><surname>Hunsicker</surname><given-names>LG</given-names></name>
<name><surname>Bain</surname><given-names>RP</given-names></name>
<name><surname>Rohde</surname><given-names>RD</given-names></name>
</person-group>. <article-title>The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group</article-title>. <source>N Engl J Med</source> <year>1993</year>; <volume>329</volume>: <fpage>1456</fpage>–<lpage>1462</lpage>.</citation>
</ref>
<ref id="bibr90-1470320311417655">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>CW</given-names></name>
<name><surname>Porro</surname><given-names>EB</given-names></name>
<name><surname>Patton</surname><given-names>JG</given-names></name>
<name><surname>Nadal-Ginard</surname><given-names>B</given-names></name>
</person-group>. <article-title>Scanning from an independently specified branch point defines the 3’ splice site of mammalian introns</article-title>. <source>Nature</source> <year>1989</year>; <volume>342</volume>: <fpage>243</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr91-1470320311417655">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Danser</surname><given-names>AH</given-names></name>
<name><surname>Schalekamp</surname><given-names>MA</given-names></name>
<name><surname>Bax</surname><given-names>WA</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism</article-title>. <source>Circulation</source> <year>1995</year>; <volume>92</volume>: <fpage>1387</fpage>–<lpage>1388</lpage>.</citation>
</ref>
<ref id="bibr92-1470320311417655">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tarnow</surname><given-names>L</given-names></name>
<name><surname>Gluud</surname><given-names>C</given-names></name>
<name><surname>Parving</surname><given-names>HH</given-names></name>
</person-group>. <article-title>Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene</article-title>. <source>Nephrol Dial Transplant</source> <year>1998</year>; <volume>13</volume>: <fpage>1125</fpage>–<lpage>1130</lpage>.</citation>
</ref>
<ref id="bibr93-1470320311417655">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kunz</surname><given-names>R</given-names></name>
<name><surname>Bork</surname><given-names>JP</given-names></name>
<name><surname>Fritsche</surname><given-names>L</given-names></name>
<name><surname>Ringel</surname><given-names>J</given-names></name>
<name><surname>Sharma</surname><given-names>AM</given-names></name>
</person-group>. <article-title>Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review</article-title>. <source>J Am Soc Nephrol</source> <year>1998</year>; <volume>9</volume>: <fpage>1653</fpage>–<lpage>1663</lpage>.</citation>
</ref>
<ref id="bibr94-1470320311417655">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ng</surname><given-names>DP</given-names></name>
<name><surname>Tai</surname><given-names>BC</given-names></name>
<name><surname>Koh</surname><given-names>D</given-names></name>
<name><surname>Tan</surname><given-names>KW</given-names></name>
<name><surname>Chia</surname><given-names>KS</given-names></name>
</person-group>. <article-title>Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects</article-title>. <source>Diabetologia</source> <year>2005</year>; <volume>48</volume>: <fpage>1008</fpage>–<lpage>1016</lpage>.</citation>
</ref>
<ref id="bibr95-1470320311417655">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egger</surname><given-names>M</given-names></name>
<name><surname>Zellweger-Zahner</surname><given-names>T</given-names></name>
<name><surname>Schneider</surname><given-names>M</given-names></name>
<name><surname>Junker</surname><given-names>C</given-names></name>
<name><surname>Lengeler</surname><given-names>C</given-names></name>
<name><surname>Antes</surname><given-names>G</given-names></name>
</person-group>. <article-title>Language bias in randomised controlled trials published in English and German</article-title>. <source>Lancet</source> <year>1997</year>; <volume>350</volume>: <fpage>326</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr96-1470320311417655">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Passaro</surname><given-names>A</given-names></name>
<name><surname>Calzoni</surname><given-names>F</given-names></name>
<name><surname>Volpato</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up</article-title>. <source>J Intern Med</source> <year>2003</year>; <volume>254</volume>: <fpage>264</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr97-1470320311417655">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname><given-names>J</given-names></name>
<name><surname>Stampfer</surname><given-names>MJ</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer</article-title>. <source>Cancer Res</source> <year>1997</year>; <volume>57</volume>: <fpage>1098</fpage>–<lpage>1102</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>